The DOJ alleged Biotheranosics promoted and performed its Breast Cancer Index test for patients who had not been in remission for five years and who had not been taking tamoxifen.
The deal ends an investigation by the SEC into certain accounting practices by Alere's foreign subsidiaries. The company also consented to a cease-and-desist order.
GNC will start using DNA testing to authentic the presence of plants included in its labels, following an agreement with the New York Attorney General.
Myriad and Quest have agreed to dismiss lawsuits, claims, counterclaims, and disputes related to Myriad's patent claims on BRCA1 and BRCA2 in the litigation.
NEW YORK (GenomeWeb) – CareDx said after the close of the market on Wednesday that it has settled a dispute with Roche over a licensing agreement forged between the two firms in late 2004.
Just days before they were scheduled to go to trial, Alnylam Pharmaceuticals and Tekmira Pharmaceuticals announced that they have hammered out a settlement to their protracted patent-infringement and technology-misappropriation lawsuits.
NEW YORK (GenomeWeb News) – Genetic Technologies today announced it has reached a settlement and licensing agreement with GeneSeek, resolving a patent dispute between the firms.
An international commission is to develop a report on how researchers, clinicians, and regulators should evaluate the clinical applications of human germline genome editing.
In Genome Research this week: repetitive element deletion linked to altered methylation and more in form of muscular dystrophy; human contamination in draft bacterial and archaeal genomes; and more.
